• High-Throughput Surrogate BBB Model: Predictive Power & Vali

  2026-04-22

  This study introduces a high-throughput in vitro blood-brain barrier (BBB) model using LLC-PK1-MOCK/MDR1 cells, integrating lysosomal trapping correction to enhance predictive accuracy for CNS drug permeability. The model demonstrates robust correlation with in vivo brain distribution, offering a scalable tool for early CNS drug candidate screening.

• Cell Surface GlycoRNA–RBP Nanodomains Enable Peptide Entry

  2026-04-22

  This study uncovers the presence and functional organization of RNA-binding proteins (RBPs) and glycoRNAs on the cell surface, forming nanoclusters that act as entry sites for cell-penetrating peptides. The findings reshape our understanding of cell surface architecture and offer methodological insights for mapping dynamic protein–RNA interactions at the membrane interface.

• Caffeine (1,3,7-trimethylpurine-2,6-dione): Lab Use Guide

  2026-04-21

  Caffeine is a purine alkaloid used in cancer biology, metabolic, and neurobiology research for its role as an adenosine receptor antagonist and metabolic regulator. This article details how to handle, solubilize, and apply Caffeine (SKU N2379) in laboratory workflows, and highlights key limitations for researchers. It should not be used where ethanol solubility or long-term solution stability is required.

• Angiotensin III (human, mouse): Reliable RAAS Peptide for Re

  2026-04-21

  This article addresses key laboratory challenges in cell viability, proliferation, and cytotoxicity assays using Angiotensin III (human, mouse) (SKU A1043). By exploring real-world scenarios, it demonstrates how validated workflows and high-purity reagents from APExBIO improve experimental reproducibility and data quality. Practical protocol guidance and literature-backed insights support confident assay design and interpretation.

• BMP4-GPX4 Axis Mitigates Ferroptosis in Glaucoma Models

  2026-04-20

  This study demonstrates that activating the BMP4-GPX4 pathway protects retinal ganglion cells from ferroptosis and enhances retinal stem cell differentiation in a mouse model of glaucoma induced by N-Methyl-D-aspartic acid (NMDA). The findings suggest a potential therapeutic approach for improving stem cell transplantation outcomes in neurodegenerative retinal disease.

• Reliable Cell Proliferation: EdU Flow Cytometry Assay Kits (

  2026-04-20

  This article examines real-world laboratory scenarios where EdU Flow Cytometry Assay Kits (Cy5) (SKU K1078) provide robust, quantitative cell proliferation analysis. Integrating peer-reviewed findings and workflow best practices, the discussion demonstrates how K1078 advances reproducibility, sensitivity, and safety for S-phase DNA synthesis measurement in biomedical research.

• Isoprinosine and Host-Directed Antiviral Immunotherapy: Next

  2026-04-19

  Explore the advanced immunomodulatory role of Isoprinosine (inosine pranobex) in viral inhibition, with a focus on unique host-cell mechanisms and translational assay guidance. This article delivers a fresh perspective grounded in cutting-edge herpesvirus research.

• Cell Surface Integrity Sets Polyploidy Limits in Budding Yea

  2026-04-18

  This study demonstrates that the upper limit of ploidy in Saccharomyces cerevisiae is constrained by cell surface integrity rather than DNA content alone. By identifying the physiological and genetic factors that limit polyploidization, the research provides new insight into the interplay between genome duplication, membrane stress, and cell viability.

• Tamsulosin in Surgical Outcomes: Meta-Analysis, Protocols, a

  2026-04-17

  Explore the advanced role of Tamsulosin in preventing postoperative urinary retention and enhancing urinary flow. This article uniquely bridges meta-analytical evidence with practical protocol guidance, offering new insights for GPCR pathway and urological disease research.

• Deferoxamine Mesylate in Metabolic Stress: From Iron Chelati

  2026-04-16

  Explore how Deferoxamine mesylate, a leading iron-chelating agent, advances research on cellular adaptation to metabolic and oxidative stress. This article uniquely connects iron handling, lysosomal regulation, and hypoxia signaling for next-generation assay development.

• GSK-923295: CENP-E Inhibitor Workflows for Mitotic Arrest

  2026-04-15

  GSK-923295 delivers highly selective, reproducible CENP-E inhibition, enabling researchers to dissect mitotic checkpoint fidelity and chromosomal alignment regulation in cancer models. With robust antitumor activity and optimized protocols, it stands out as a reliable tool for cell cycle and centromere research, directly translating mechanistic insights into actionable experimental results.

• U 46619: Mechanistic Edge for Translational Platelet Researc

  2026-04-14

  Explore how U 46619 (11,9 epoxymethano-prostaglandin H2) empowers translational researchers to bridge mechanistic platelet and vascular biology with high-impact preclinical models. This article blends deep mechanistic insight, evidence-based protocol guidance, and strategic positioning for robust, reproducible studies—escalating the conversation beyond conventional product guides.

• Real-World Solutions with c-Myc tag Peptide (SKU A6003)

  2026-04-13

  This article delivers scenario-driven guidance for deploying c-Myc tag Peptide (SKU A6003) in immunoassays, focusing on reproducibility, sensitivity, and protocol optimization. Using real laboratory challenges, it demonstrates how this synthetic peptide from APExBIO addresses common pain points in antibody inhibition, workflow compatibility, and data reliability. All guidance is grounded in peer-reviewed evidence or validated product specifications.

• Radioiodinated Balsalazide as a Selective UC Radiotracer in

  2026-04-12

  Sanad et al. developed and characterized a highly selective radioiodinated balsalazide tracer for imaging ulcerative colitis (UC) in mice, achieving high labeling yield and stability. Their approach addresses prior limitations in radiotracer follow-up and supports improved preclinical imaging of UC tissue involvement.

• Ibuprofen in Translational Oncology: Mechanisms and Strategy

  2026-04-12

  A thought-leadership article for translational researchers, integrating mechanistic insights and strategic guidance on the use of Ibuprofen (2-[4-(2-methylpropyl)phenyl]propanoic acid) as an anti-proliferative agent in colon cancer models. The piece contextualizes recent research on drug-protein interactions, best practices for experimental design, and translational considerations—offering a roadmap that expands beyond conventional workflows and vendor specifications.

16228 records 1/1082 page Next 12345 下5页 Last page